| Structure | Chemical Name | CAS | MF |
|
Sirm protein
|
|
|
|
|
siroamide
|
|
|
|
Sirodesmin B
|
52988-51-9
|
C20H26N2O8S4
|
|
Sirodesmin C
|
52988-52-0
|
C20H26N2O8S3
|
|
sirohydrochlorin
|
65207-12-7
|
C42H46N4O16
|
|
|
sirohaem sulfite reductase
|
|
|
|
siroheme
|
52553-42-1
|
C42H37FeN4O16(-7)
|
|
SiroliMus-D3/ RapaMycin-D3
|
392711-19-2
|
C51H76D3NO13
|
|
Rapamycin
|
53123-88-9
|
C51H79NO13
|
|
|
Sirolimus-Rapamycintacrolimus
|
|
|
|
|
Sirolimus(Rapamycin)
|
|
|
|
|
SIRP-B2 protein
|
|
|
|
|
SIR1 protein
|
135844-02-9
|
|
|
|
SIR2 protein
|
|
|
|
|
SIR3 protein
|
94895-23-5
|
|
|
|
SIR4 protein
|
|
|
|
|
SirR protein
|
|
|
|
SIRT1 ACTIVATOR 3
|
839699-72-8
|
C20H25N5O2
|
|
|
SI-SILVER NITRATE
|
|
|
|
|
SIRT6 Direct Fluorophore
|
|
|
|
|
SIRT3 Direct Peptide
|
|
|
|
|
SIRT1 Direct Developer
|
|
|
|
|
SIRT3 Direct NAD+
|
|
|
|
|
SIRT6 Direct Assay Buffer (10X)
|
|
|
|
|
SIRT3 Direct Assay Buffer (10X)
|
|
|
|
|
SIRT2 Direct NAD+
|
|
|
|
|
SIRT1 Direct Nicotinamide
|
|
|
|
|
SIRT6 Direct Nicotinamide
|
|
|
|
|
SIRT3 Direct Fluorophore
|
|
|
|
|
SIRT2 Direct Developer
|
|
|
|
|
SIRT6 Direct Fluorescent Screening Assay Kit
|
|
|
|
|
SIRT1 Direct NAD+
|
|
|
|
|
SIRT3 Direct Fluorescent Screening Assay Kit
|
|
|
|
|
SIRT6 Direct Peptide
|
|
|
|
|
SIRT3 Direct Nicotinamide
|
|
|
|
|
SIRT2 Direct Fluorophore
|
|
|
|
|
SIRT6 Direct NAD+
|
|
|
|
|
SIRT2 Direct Assay Buffer (10X)
|
|
|
|
|
SIRT1 Direct Assay Buffer (10X)
|
|
|
|
|
SIRT6 Direct Developer
|
|
|
|
|
SIRT2 Direct Fluorescent Screening Assay Kit
|
|
|
|
|
SIRT1 Direct Fluorophore
|
|
|
|
|
SIRT1 Direct Peptide
|
|
|
|
|
SIRT2 Direct Peptide
|
|
|
|
|
SIRT2 Direct Nicotinamide
|
|
|
|
|
SIRT1 Direct Fluorescent Screening Assay Kit
|
|
|
|
|
SIRT3 Direct Developer
|
|
|
|
|
SI/SIO2 THICKNESS-10 NM
|
|
|
|
|
SIRT1 FRET Fluorophore
|
|
|
|
|
SIRT1 FRET-Based Screening Assay Kit
|
|
|
|
|
SIRT1 FRET Peptide
|
|
|
|
|
SIRT1 FRET Developer
|
|
|
|
|
SIRT1 FRET Stop Solution
|
|
|
|
|
SIRT1 FRET NAD+
|
|
|
|
|
SIRT1 FRET Assay Buffer (10X)
|
|
|
|
|
SIRT5 (human recombinant)
|
|
|
|
|
SIRT4 (human recombinant)
|
|
|
|
|
SIRT2 (human recombinant)
|
|
|
|
|
SIRT1 (human recombinant) FRET Assay Reagent
|
|
|
|
|
SIRT7 (human recombinant)
|
|
|
|
|
SIRT3 (human recombinant) Direct Assay Reagent
|
|
|
|
|
SIRT6 (human recombinant) Direct Assay Reagent
|
|
|
|
|
SIRT1 (human recombinant)
|
|
|
|
|
SIRT3 (human recombinant)
|
|
|
|
|
SIRT2 (human recombinant) Direct Assay Reagent
|
|
|
|
|
SIRT1 (human recombinant) Direct Assay Reagent
|
|
|
|
|
SIRT6 (human recombinant)
|
|
|
|
SIRT2 Inhibitor, Inactive Control, AGK7
|
304896-21-7
|
C23H13Cl2N3O2
|
|
SIRTINOL
|
410536-97-9
|
C26H22N2O2
|
|
|
SI-TAA ACID
|
|
|
|
|
SI-TAA SODIUM SALT
|
|
|
|
|
SITAC protein
|
|
|
|
|
SIRT7 Polyclonal Antibody
|
|
|
|
|
Sitafloxacine
|
|
|
|
Sitafloxacin Sesquihydrate
|
163253-35-8
|
C19H20ClF2N3O4
|
|
Sitafloxacin
|
127254-12-0
|
C19H18ClF2N3O3
|
|
Sitagliptin N-Sulfate
|
940002-57-3
|
C16H15F6N5O4S
|
|
Sitagliptin Carbamoyl -D-Glucuronide
|
940002-59-5
|
C23H23F6N5O9
|
|
Sitagliptin CarbaMoyl β-D-Glucuronide Methyl Ester
|
|
C24H25F6N5O9
|
|
Sitagliptin CarbaMoyl Tri-O-acetyl-β-D-glucuronide Methyl Ester
|
|
C30H31F6N5O12
|
|
Sitagliptin Phosphate
|
847445-79-8
|
|
|
Sitagliptin phosphate
|
654671-78-0
|
C16H15F6N5O.H3PO4
|
|
Vildagliptin
|
274901-16-5
|
C17H25N3O2
|
|
Sitagliptin
|
486460-32-6
|
C16H15F6N5O
|
|
Sitagliptin phosphate monohydrate
|
654671-77-9
|
C16H18F6N5O5P
|
|
|
SI-TBA CHLORIDE
|
|
|
|
Sitalidone
|
108894-39-9
|
C23H29ClN2O5S
|
|
SITAMAQUINE,N,N-DIETHYL-N'-(6-METHOXY-4-METHYL-QUINOLIN-8-YL)-HEXANE-1,6-DIAMINE
|
57695-04-2
|
C21H33N3O
|
|
|
SI-TBD
|
|
|
|
Sitaxsentan-13C4 Sodium
|
|
C18H14ClN2NaO6S2
|
|
Sitaxentan sodium
|
210421-74-2
|
C18H14ClN2NaO6S2
|
|
S-Isoamyl-L-Cysteine
|
|
C8H17NO2S
|
|
(3S)-3-Isobutyl-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione
|
104874-01-3
|
C13H16N2O2
|
|
S-2-ISOBUTYL-PIPERAZINE-2HCl
|
1240620-73-8
|
C8H19ClN2
|
|
S-Isobutyl-L-cysteine
|
|
C7H15NO2S
|
|
(3S)-3-ISOBUTYL-7-METHANESULFONYL-4-(4-TRIFLUOROMETHYL-BENZOYL)-3,4-DIHYDRO-1H-QUINOXALIN-2-ONE
|
|
C21H21F3N2O4S
|
|
(S)-(-)-2-ISOBUTYLSUCCINIC ACID 1-METHYL ESTER
|
213270-36-1
|
C9H16O4
|
|
(3S)-3-ISOBUTYL-7-METHANESULFONYL-4-PHENYLACETYL-3,4-DIHYDRO-1H-QUINOXALIN-2-ONE
|
|
C21H24N2O4S
|
|
(S)-(-)-4-ISOBUTYLOXAZOLIDINE-2,5-DIONE
|
3190-70-3
|
C7H11NO3
|
|
(4S)-ISOBUTYL-(3S)-METHYLPYRROLIDIN-2-ONE
|
|
C9H17NO
|